<DOC>
	<DOC>NCT00288652</DOC>
	<brief_summary>The purpose of this study is to determine the effectiveness of different doses of [S,S]-Reboxetine in the treatment of chronic pain following a shingles infection</brief_summary>
	<brief_title>[S,S]-Reboxetine Dose-Range Finding Trial</brief_title>
	<detailed_description />
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Patients must have pain present for more than 3 months after the healing of shingles skin rash Patients at screening must have a score &gt;/=40 mm on the pain visual analogue scale Patients with significant renal and hepatic impairment Patients with other severe pain, that may impair the selfassessment of the pain due to shingles Patients with clinically abnormal electrocardiogram</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>